인체폐암세포의 증식 및 prostaglandin E2 생성에 미치는 청조구폐탕의 영향에 관한 연구
Antiproliferative Effect of Chungjogupae-tang Treatment was Associated with the Inhibition of Prostaglandin E2 Release in Human Lung Carcinoma Cells
0
조회
0
다운로드
1
인용
0
참고문헌
초록
Abstract
The effect of water extract of Chungjogupae-tang (CJGPT) was investigated on the growth of human lung carcinoma A549 cells. Methods: MTT assay and fluorescent microscope performed to compare and examine the efficacy of CJGPT treatment on the cytostaticity of lung cancer cells in proportion to time and doses, and DAPI staining and Western blot analysis were used to examine their effect on apoptosis. In addition, the quantitative RT-PCR was used to examine to lung cancer cells growth, and Prostaglandin E2 activity were measured. Results: Exposure of A549 cells to CJGPT resulted in the growth inhibition and apoptosis in a dose-dependent manner as measured by MTT assay and fluorescent microscope. The antiproliferative effect by CJGPT treatment in A549 cells was associated with morphological changes such as membrane shrinking and cell rounding up. CJGPT treatment resulted in an up-regulation of cyclin-dependent kinase inhibitor p21(WAF1/CIP1) in a p53-independent fashion. We found that CJGPT treatment decreased the levels of cyclooxygenase (COX)-2 and inducible nitric oxide synthease (iNOS) expression without significant changes in the expression of COX-1, which was correlated with a decrease in prostaglandin E2 (PGE2) synthesis. Conclusion: These findings suggested that CJGPT-induced inhibition of human lung carcinoma A549 cell growth was connected with the induction of apoptotic cell death and the results provided important new insights into the possible molecular mechanisms of the anti-cancer activity of CJGPT.
참고문헌 (22)
- 통계청, "2001년 사망원인통계결과" (2002), p 11
- 全國韓醫科大學 肺系內科學敎室, "東醫肺系內科學 12", pp.~392 (2002), 문화사
- 윤창열, "난경연구집성", pp.768~769 (2002), 주민출판사
- Park, D.I,, "Induction of apoptosis and inhibition of telomerase activity by aqueous extract from Platycodon grandiflorum in human lung carcinoma cells", pp.437~443 (2005)
- Harper, J.W, "Cyclin dependent kinase inhibitors", pp.91~107 (1997)
- Li, "Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21", pp.2261~9 2268 (1994)
- Taylor, W.R, "2001 Regulation of the G2", M transition by p53, 2001, ~20
- Datto, M.B.,, "Functional analysis of the transforming growth factor β responsive elements in the WAF1", Cip1, pp.1995[DOI]
- Zeng, Y.X., "Regulation of p21WAF1", CIP1 expression by p53-independent pathways, 1996, 1557~12 1564
- Choi, Y.H.,, "p53-independent induction of p21 reduction of cyclin B1 and G2", M arrest by the isoflavone genistein in human prostate carcinoma cells, 2000, 164~173
- Xiong, "p21 is a universal inhibitor of cyclin kinases", pp.701~366 704 (1993)
- Tchou, W.W.,, "Novel form of p21 protein in phorbol ester-induced G2", M arrest, 1996, 29556~29560
- Dulic, V.,, "Nuclear accumulation of p21Cip1 at the onset of mitosis a role at the G2", M-phase transition, 1998, 546~557
- Musgrove, E.A.,, "Role of the CDK Inhibitor p27 Insights from knockout mice", pp.55~9 66 (2004)
- Giercksky, K.E, "COX-2 inhibition and prevention of cancer", pp.821~833 (2001)
- Thun, M.J.,, "Nonsteroidal anti- inflammatory drugs as anticancer agents", and patro, pp.252~266 (2002)
- Vainio, H., "Is COX-2 inhibition a panacea for cancer prevention", pp.613~614 (2001)
- Dempke, W.,, "Cyclooxygenase-2: a novel target for cancer chemotherapy", pp.411~2 417 (2001)
- Surh, Y.J.,, "Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals down-regulation of COX-2 and iNOS through suppression of NF-κB activation", pp.480 243~481 268 (2001)
- Sawaoka, H.,, "Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo", pp.1469~1477 (1999)
- Yamamoto, Y, "Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer", pp.135~142 (2001)
- Yamamoto, Y., "Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer", pp.135~142 (2001)